Optimizing Quality & Safety Systems to Reduce the Risk of Patient Harm
Jacob Sands, MD
Joseph O. Jacobson, MD
A Review of the Multiple Myeloma Treatment Journey
Charles Turck, PharmD, BCPS, BCCCP
Morie Gertz, MD, MACP
Aaron Rosenberg, MD, MS
Managing Multiple Myeloma Patients: Providing Better Care
Noopur Raje, MD
Shaji K. Kumar, MD
Expert Perspectives on Treating Relapsed or Refractory Multiple Myeloma
Ravi Vij, MD
Addressing the Challenge in Rechallenge Strategies for mCRC
Fortunato Ciardiello, MD, PhD
Erika Martinelli, MD, PhD
What Are the Clinical Features of HER2 Amplified Colorectal Cancers?
Andrea Cercek, MD
HER2-Directed TKI Combinations in mCRC: Improving Adherence Through Proactive ADR Monitoring and Management
John H. Strickler, MD
Managing PNH Patients: Addressing the Unmet Needs
Brian Mulherin, MD
Conquering the Burden & Impacts of PNH
Hana Safah, MD
Timothy Kubal, MD
Improving PNH Patient Outcomes
David Dingli, MD, PhD
How Do We Make Sense of Guidelines and Apply to Our Everyday Practice?
Cihan Ay, MD
Jean M. Connors, MD
Alok A. Khorana, MD
Primary Thromboprophylaxis of Patient at High-Risk of VTE Who Is Receiving Systemic Anticancer Therapy
Treatment of Patient With Low Risk of Genitourinary Bleed for Established VTE With Cancer
Treatment of Patient With Low Risk of Gastrointestinal Absorption Impairment for Established VTE With Cancer
Treatment of Patients With Established VTE With Cancer and COVID-19
Prophylaxis of Medically Treated Patient With Cancer and Reduced Mobility in Hospital
Loading...
Stay current with the best on medical education
NEW FEATURES:
Tell us what you think by using the Feedback button on the right side of the page.
We’re glad to see you’re enjoying Global Oncology Academy…but how about a more personalized experience?
Press cancel to remain on Global Oncology Academy. Press the link below or the continue button to keep going.
